Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gait | 40 | 2022 | 404 | 8.600 |
Why?
|
Hip Prosthesis | 34 | 2022 | 605 | 5.670 |
Why?
|
Knee Prosthesis | 22 | 2020 | 248 | 4.860 |
Why?
|
Arthroplasty, Replacement, Knee | 22 | 2021 | 696 | 4.830 |
Why?
|
Knee Joint | 32 | 2022 | 797 | 4.770 |
Why?
|
Prosthesis Failure | 32 | 2021 | 556 | 4.380 |
Why?
|
Polyethylene | 19 | 2020 | 116 | 4.240 |
Why?
|
Walking | 15 | 2022 | 252 | 4.210 |
Why?
|
Arthroplasty, Replacement, Hip | 30 | 2021 | 863 | 3.900 |
Why?
|
Models, Biological | 15 | 2018 | 343 | 3.200 |
Why?
|
Biomechanical Phenomena | 40 | 2022 | 668 | 3.050 |
Why?
|
Biocompatible Materials | 13 | 2020 | 114 | 3.010 |
Why?
|
Materials Testing | 23 | 2021 | 137 | 2.910 |
Why?
|
Equipment Failure Analysis | 21 | 2016 | 106 | 2.850 |
Why?
|
Osteoarthritis, Hip | 12 | 2018 | 94 | 2.810 |
Why?
|
Polyethylenes | 12 | 2020 | 50 | 2.800 |
Why?
|
Cartilage, Articular | 16 | 2020 | 524 | 2.590 |
Why?
|
Hip Joint | 13 | 2016 | 367 | 2.510 |
Why?
|
Titanium | 17 | 2023 | 209 | 2.340 |
Why?
|
Prosthesis Design | 22 | 2021 | 502 | 2.180 |
Why?
|
Alloys | 16 | 2021 | 102 | 2.060 |
Why?
|
Range of Motion, Articular | 17 | 2019 | 699 | 2.030 |
Why?
|
Humans | 116 | 2023 | 29337 | 1.820 |
Why?
|
Tibia | 10 | 2022 | 259 | 1.800 |
Why?
|
Protein Tyrosine Phosphatases | 4 | 2014 | 8 | 1.640 |
Why?
|
Shoes | 5 | 2022 | 29 | 1.640 |
Why?
|
Metals | 9 | 2022 | 160 | 1.620 |
Why?
|
Osteoarthritis, Knee | 12 | 2019 | 381 | 1.610 |
Why?
|
Middle Aged | 51 | 2020 | 9823 | 1.580 |
Why?
|
Stress, Mechanical | 22 | 2020 | 166 | 1.540 |
Why?
|
Surface Properties | 29 | 2021 | 144 | 1.520 |
Why?
|
Knee | 7 | 2017 | 44 | 1.510 |
Why?
|
Male | 59 | 2020 | 15621 | 1.480 |
Why?
|
Corrosion | 18 | 2022 | 139 | 1.430 |
Why?
|
Chondrocytes | 9 | 2015 | 197 | 1.410 |
Why?
|
Mechanical Phenomena | 7 | 2022 | 22 | 1.360 |
Why?
|
Female | 57 | 2021 | 16197 | 1.350 |
Why?
|
Aged | 44 | 2022 | 9448 | 1.350 |
Why?
|
Europium | 3 | 2020 | 5 | 1.270 |
Why?
|
Stearates | 3 | 2020 | 5 | 1.270 |
Why?
|
Steel | 2 | 2020 | 2 | 1.210 |
Why?
|
Prosthesis-Related Infections | 4 | 2023 | 214 | 1.210 |
Why?
|
Pressure | 6 | 2020 | 59 | 1.180 |
Why?
|
Aluminum Oxide | 3 | 2019 | 7 | 1.180 |
Why?
|
Vitallium | 6 | 2013 | 25 | 1.100 |
Why?
|
Weight-Bearing | 18 | 2020 | 164 | 1.090 |
Why?
|
Nickel | 2 | 2021 | 29 | 1.020 |
Why?
|
Prostheses and Implants | 7 | 2016 | 166 | 0.990 |
Why?
|
Dental Implants | 3 | 2012 | 8 | 0.970 |
Why?
|
Aged, 80 and over | 24 | 2020 | 4851 | 0.970 |
Why?
|
Nanotubes | 1 | 2023 | 3 | 0.940 |
Why?
|
Chitosan | 1 | 2023 | 4 | 0.930 |
Why?
|
Postoperative Complications | 5 | 2017 | 957 | 0.920 |
Why?
|
Anterior Cruciate Ligament | 3 | 2018 | 270 | 0.890 |
Why?
|
Electromyography | 7 | 2018 | 78 | 0.860 |
Why?
|
Muscle, Skeletal | 10 | 2018 | 349 | 0.840 |
Why?
|
Movement | 8 | 2016 | 143 | 0.840 |
Why?
|
Bioreactors | 4 | 2014 | 6 | 0.830 |
Why?
|
Cell Culture Techniques | 4 | 2014 | 44 | 0.810 |
Why?
|
Cobalt | 8 | 2016 | 116 | 0.810 |
Why?
|
Arthroplasty, Replacement | 3 | 2020 | 147 | 0.810 |
Why?
|
Chromium | 7 | 2016 | 92 | 0.800 |
Why?
|
Adult | 27 | 2019 | 8601 | 0.800 |
Why?
|
Metal-on-Metal Joint Prostheses | 5 | 2014 | 57 | 0.790 |
Why?
|
Mitochondrial Proteins | 2 | 2011 | 21 | 0.750 |
Why?
|
Femur | 6 | 2019 | 396 | 0.730 |
Why?
|
Proteoglycans | 5 | 2017 | 337 | 0.720 |
Why?
|
Ankle Injuries | 3 | 2016 | 12 | 0.700 |
Why?
|
Feedback, Sensory | 1 | 2019 | 7 | 0.700 |
Why?
|
Smartphone | 1 | 2019 | 15 | 0.700 |
Why?
|
Foot | 2 | 2016 | 30 | 0.690 |
Why?
|
Joint Prosthesis | 2 | 2018 | 83 | 0.690 |
Why?
|
Arthroplasty, Replacement, Ankle | 1 | 2018 | 2 | 0.670 |
Why?
|
Animals | 26 | 2021 | 4552 | 0.670 |
Why?
|
Friction | 10 | 2020 | 20 | 0.650 |
Why?
|
Feedback | 2 | 2016 | 31 | 0.640 |
Why?
|
Cattle | 13 | 2020 | 217 | 0.630 |
Why?
|
Lipopolysaccharides | 3 | 2013 | 127 | 0.610 |
Why?
|
Device Removal | 6 | 2020 | 85 | 0.610 |
Why?
|
Electrochemistry | 9 | 2017 | 44 | 0.600 |
Why?
|
Cicatrix | 1 | 2016 | 12 | 0.580 |
Why?
|
Synovial Fluid | 5 | 2021 | 123 | 0.560 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2014 | 5 | 0.550 |
Why?
|
14-3-3 Proteins | 2 | 2014 | 4 | 0.550 |
Why?
|
Joints | 2 | 2016 | 97 | 0.550 |
Why?
|
Recovery of Function | 4 | 2014 | 290 | 0.550 |
Why?
|
Walking Speed | 1 | 2016 | 41 | 0.540 |
Why?
|
Auditory Perception | 1 | 2016 | 36 | 0.540 |
Why?
|
Purkinje Cells | 1 | 2014 | 2 | 0.520 |
Why?
|
Cartilage | 2 | 2019 | 148 | 0.520 |
Why?
|
Severity of Illness Index | 4 | 2013 | 1113 | 0.510 |
Why?
|
Stainless Steel | 3 | 2021 | 17 | 0.510 |
Why?
|
RNA, Messenger | 7 | 2014 | 323 | 0.480 |
Why?
|
Hyperkinesis | 1 | 2013 | 11 | 0.480 |
Why?
|
Metals, Heavy | 1 | 2013 | 7 | 0.480 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2013 | 20 | 0.470 |
Why?
|
Algorithms | 2 | 2014 | 400 | 0.470 |
Why?
|
Radiography | 8 | 2018 | 678 | 0.470 |
Why?
|
Motion | 3 | 2011 | 24 | 0.470 |
Why?
|
Rotation | 6 | 2019 | 142 | 0.460 |
Why?
|
Acetabulum | 5 | 2012 | 208 | 0.460 |
Why?
|
Beryllium | 1 | 2013 | 1 | 0.460 |
Why?
|
Microscopy, Electron, Scanning | 11 | 2013 | 86 | 0.460 |
Why?
|
Blood Proteins | 1 | 2012 | 20 | 0.450 |
Why?
|
Memory | 1 | 2014 | 318 | 0.450 |
Why?
|
Computer Simulation | 6 | 2020 | 218 | 0.450 |
Why?
|
Mouth | 1 | 2012 | 11 | 0.440 |
Why?
|
Baseball | 4 | 2017 | 105 | 0.440 |
Why?
|
Hippocampus | 1 | 2014 | 274 | 0.440 |
Why?
|
Activities of Daily Living | 1 | 2015 | 501 | 0.420 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 28 | 0.420 |
Why?
|
Glioblastoma | 1 | 2011 | 10 | 0.420 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 38 | 0.410 |
Why?
|
Gene Expression | 2 | 2015 | 226 | 0.400 |
Why?
|
Particle Size | 7 | 2013 | 78 | 0.400 |
Why?
|
Glycoproteins | 3 | 2007 | 58 | 0.400 |
Why?
|
Microcirculation | 4 | 2007 | 37 | 0.390 |
Why?
|
Fragile X Syndrome | 1 | 2013 | 189 | 0.390 |
Why?
|
Brain Neoplasms | 1 | 2011 | 124 | 0.380 |
Why?
|
Zirconium | 2 | 2019 | 4 | 0.370 |
Why?
|
Transplants | 1 | 2009 | 11 | 0.370 |
Why?
|
Risk Factors | 8 | 2017 | 2443 | 0.360 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 333 | 0.350 |
Why?
|
Graft Survival | 1 | 2009 | 98 | 0.350 |
Why?
|
Time Factors | 12 | 2016 | 1616 | 0.350 |
Why?
|
Muscle Strength | 5 | 2019 | 127 | 0.340 |
Why?
|
Surgery, Computer-Assisted | 2 | 2006 | 60 | 0.340 |
Why?
|
Equipment Design | 5 | 2019 | 185 | 0.340 |
Why?
|
Carcinoma, Basal Cell | 1 | 2008 | 7 | 0.340 |
Why?
|
Keratinocytes | 1 | 2008 | 12 | 0.330 |
Why?
|
Ankle Joint | 4 | 2016 | 39 | 0.330 |
Why?
|
Models, Theoretical | 2 | 2020 | 91 | 0.330 |
Why?
|
Hydrogen-Ion Concentration | 8 | 2021 | 148 | 0.330 |
Why?
|
Reoperation | 7 | 2014 | 932 | 0.330 |
Why?
|
Osteolysis | 3 | 2016 | 149 | 0.330 |
Why?
|
Stromal Cells | 1 | 2008 | 35 | 0.330 |
Why?
|
Dental Alloys | 3 | 2013 | 4 | 0.330 |
Why?
|
Hyaluronic Acid | 3 | 2021 | 94 | 0.320 |
Why?
|
Skin Neoplasms | 1 | 2008 | 65 | 0.320 |
Why?
|
Nitrogen | 2 | 2021 | 4 | 0.320 |
Why?
|
Polyurethanes | 2 | 2006 | 9 | 0.310 |
Why?
|
Adaptation, Biological | 1 | 2007 | 3 | 0.310 |
Why?
|
Synovial Membrane | 1 | 2007 | 81 | 0.310 |
Why?
|
Anterior Cruciate Ligament Injuries | 2 | 2022 | 259 | 0.300 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2008 | 178 | 0.300 |
Why?
|
In Vitro Techniques | 3 | 2016 | 213 | 0.280 |
Why?
|
Joint Diseases | 1 | 2007 | 110 | 0.280 |
Why?
|
Elbow Joint | 3 | 2015 | 131 | 0.280 |
Why?
|
Molybdenum | 4 | 2016 | 22 | 0.280 |
Why?
|
Femur Head | 1 | 2006 | 66 | 0.280 |
Why?
|
Case-Control Studies | 5 | 2016 | 638 | 0.280 |
Why?
|
Implants, Experimental | 2 | 2021 | 29 | 0.280 |
Why?
|
Exercise Test | 1 | 2006 | 122 | 0.270 |
Why?
|
Microscopy, Electron, Transmission | 5 | 2013 | 30 | 0.270 |
Why?
|
Tissue Engineering | 2 | 2006 | 36 | 0.270 |
Why?
|
Saliva, Artificial | 4 | 2013 | 4 | 0.270 |
Why?
|
Foreign Bodies | 2 | 2003 | 25 | 0.260 |
Why?
|
Joint Instability | 1 | 2009 | 387 | 0.260 |
Why?
|
Foreign-Body Reaction | 3 | 2014 | 32 | 0.260 |
Why?
|
Osteoarthritis | 2 | 2022 | 363 | 0.260 |
Why?
|
Immunohistochemistry | 3 | 2011 | 391 | 0.260 |
Why?
|
Treatment Outcome | 10 | 2016 | 3478 | 0.260 |
Why?
|
Mechanotransduction, Cellular | 1 | 2004 | 5 | 0.260 |
Why?
|
Cell Survival | 3 | 2017 | 169 | 0.250 |
Why?
|
Finite Element Analysis | 3 | 2020 | 44 | 0.250 |
Why?
|
Reference Values | 3 | 2017 | 227 | 0.250 |
Why?
|
Microspheres | 1 | 2004 | 32 | 0.250 |
Why?
|
Young Adult | 7 | 2016 | 1932 | 0.250 |
Why?
|
Physical Examination | 2 | 2015 | 117 | 0.240 |
Why?
|
Reproducibility of Results | 5 | 2022 | 788 | 0.240 |
Why?
|
Up-Regulation | 4 | 2011 | 174 | 0.240 |
Why?
|
Spinal Diseases | 1 | 2006 | 150 | 0.240 |
Why?
|
Cells, Cultured | 4 | 2014 | 676 | 0.240 |
Why?
|
Intervertebral Disc | 1 | 2006 | 212 | 0.240 |
Why?
|
Metal Nanoparticles | 3 | 2013 | 11 | 0.240 |
Why?
|
Gentamicins | 1 | 2023 | 16 | 0.230 |
Why?
|
Sensitivity and Specificity | 4 | 2012 | 553 | 0.230 |
Why?
|
Shoulder Joint | 3 | 2015 | 572 | 0.230 |
Why?
|
Transplantation, Homologous | 2 | 2017 | 277 | 0.220 |
Why?
|
Bone Cements | 3 | 2012 | 99 | 0.220 |
Why?
|
Ceramics | 2 | 2019 | 23 | 0.210 |
Why?
|
Analysis of Variance | 3 | 2012 | 321 | 0.210 |
Why?
|
Internationality | 3 | 2012 | 24 | 0.210 |
Why?
|
Healthy Volunteers | 2 | 2019 | 46 | 0.210 |
Why?
|
Lubrication | 3 | 2020 | 5 | 0.200 |
Why?
|
Inflammation | 3 | 2020 | 344 | 0.200 |
Why?
|
In Situ Hybridization | 2 | 2011 | 46 | 0.200 |
Why?
|
Osseointegration | 1 | 2021 | 76 | 0.200 |
Why?
|
Mice | 3 | 2021 | 1607 | 0.190 |
Why?
|
Pain | 4 | 2013 | 391 | 0.190 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 145 | 0.190 |
Why?
|
Mass Spectrometry | 1 | 2000 | 41 | 0.180 |
Why?
|
Brain | 1 | 2009 | 1689 | 0.180 |
Why?
|
Cross-Linking Reagents | 2 | 2011 | 15 | 0.180 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 402 | 0.180 |
Why?
|
Nebulizers and Vaporizers | 1 | 2000 | 15 | 0.180 |
Why?
|
Follow-Up Studies | 2 | 2017 | 1830 | 0.170 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 176 | 0.170 |
Why?
|
Carbon | 3 | 2013 | 10 | 0.170 |
Why?
|
Muscle Contraction | 2 | 2015 | 83 | 0.170 |
Why?
|
Risk Assessment | 2 | 2012 | 679 | 0.170 |
Why?
|
Feasibility Studies | 2 | 2016 | 227 | 0.170 |
Why?
|
Bone Density | 2 | 2011 | 134 | 0.160 |
Why?
|
Shoulder | 2 | 2017 | 154 | 0.160 |
Why?
|
Proprioception | 2 | 2014 | 19 | 0.160 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 33 | 0.150 |
Why?
|
Stair Climbing | 1 | 2017 | 5 | 0.150 |
Why?
|
Body Mass Index | 2 | 2018 | 428 | 0.150 |
Why?
|
Reference Standards | 3 | 2018 | 33 | 0.150 |
Why?
|
Lower Extremity | 1 | 2017 | 38 | 0.150 |
Why?
|
Extremities | 1 | 2016 | 31 | 0.140 |
Why?
|
Upper Extremity | 1 | 2017 | 49 | 0.140 |
Why?
|
Principal Component Analysis | 1 | 2016 | 26 | 0.140 |
Why?
|
Gene Expression Regulation | 3 | 2009 | 284 | 0.140 |
Why?
|
Escherichia coli | 2 | 2013 | 59 | 0.140 |
Why?
|
Spectrum Analysis | 3 | 2011 | 9 | 0.140 |
Why?
|
Age Factors | 2 | 2016 | 843 | 0.140 |
Why?
|
Hamstring Muscles | 1 | 2016 | 14 | 0.140 |
Why?
|
Rheology | 2 | 2006 | 3 | 0.140 |
Why?
|
Pilot Projects | 3 | 2013 | 394 | 0.140 |
Why?
|
Cadaver | 3 | 2022 | 359 | 0.140 |
Why?
|
Deltoid Muscle | 1 | 2015 | 6 | 0.140 |
Why?
|
Thigh | 1 | 2015 | 34 | 0.140 |
Why?
|
Patient Positioning | 1 | 2015 | 38 | 0.130 |
Why?
|
Allografts | 1 | 2017 | 180 | 0.130 |
Why?
|
Genome, Human | 1 | 2015 | 49 | 0.130 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 2014 | 2 | 0.130 |
Why?
|
Inflammation Mediators | 1 | 2015 | 83 | 0.130 |
Why?
|
Diacylglycerol Kinase | 1 | 2014 | 4 | 0.130 |
Why?
|
Vesicular Transport Proteins | 1 | 2014 | 9 | 0.130 |
Why?
|
Mesocricetus | 5 | 2007 | 5 | 0.130 |
Why?
|
Protein Transport | 1 | 2014 | 38 | 0.130 |
Why?
|
Cricetinae | 5 | 2007 | 36 | 0.130 |
Why?
|
Quadriceps Muscle | 2 | 2016 | 27 | 0.130 |
Why?
|
Endoplasmic Reticulum | 1 | 2014 | 28 | 0.130 |
Why?
|
Cytokines | 1 | 2017 | 347 | 0.130 |
Why?
|
Autopsy | 1 | 2016 | 335 | 0.130 |
Why?
|
Oxidation-Reduction | 2 | 2011 | 73 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 145 | 0.130 |
Why?
|
Mitochondria | 1 | 2014 | 78 | 0.120 |
Why?
|
NF-kappa B | 1 | 2014 | 107 | 0.120 |
Why?
|
Pyramidal Cells | 1 | 2014 | 44 | 0.120 |
Why?
|
Child | 3 | 2015 | 1346 | 0.120 |
Why?
|
Cell Line | 1 | 2014 | 298 | 0.120 |
Why?
|
Gamma Rays | 2 | 2011 | 16 | 0.120 |
Why?
|
Dental Materials | 1 | 2013 | 2 | 0.120 |
Why?
|
Interferometry | 2 | 2013 | 5 | 0.120 |
Why?
|
Microscopy, Electrochemical, Scanning | 1 | 2013 | 1 | 0.120 |
Why?
|
Task Performance and Analysis | 1 | 2013 | 55 | 0.120 |
Why?
|
Membrane Proteins | 1 | 2014 | 173 | 0.120 |
Why?
|
Foot Orthoses | 1 | 2013 | 11 | 0.120 |
Why?
|
Molecular Weight | 3 | 2010 | 45 | 0.120 |
Why?
|
Sleep | 1 | 2016 | 313 | 0.110 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 432 | 0.110 |
Why?
|
Bone Malalignment | 1 | 2013 | 20 | 0.110 |
Why?
|
Macrophages | 1 | 2014 | 128 | 0.110 |
Why?
|
Anterior Cruciate Ligament Reconstruction | 1 | 2016 | 235 | 0.110 |
Why?
|
Rotator Cuff | 1 | 2015 | 265 | 0.110 |
Why?
|
Adolescent | 3 | 2015 | 2279 | 0.110 |
Why?
|
Shear Strength | 1 | 2012 | 7 | 0.110 |
Why?
|
Orthopedics | 2 | 2012 | 127 | 0.110 |
Why?
|
Graphite | 1 | 2011 | 3 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2011 | 5 | 0.110 |
Why?
|
src-Family Kinases | 1 | 2011 | 8 | 0.110 |
Why?
|
Germany | 1 | 2011 | 11 | 0.110 |
Why?
|
Somatosensory Disorders | 1 | 2012 | 10 | 0.110 |
Why?
|
Tenodesis | 1 | 2014 | 152 | 0.100 |
Why?
|
Neoplasm Grading | 1 | 2011 | 45 | 0.100 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2011 | 47 | 0.100 |
Why?
|
Vibration | 1 | 2012 | 26 | 0.100 |
Why?
|
Aluminum | 1 | 2011 | 11 | 0.100 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 11 | 0.100 |
Why?
|
Microscopy, Electron | 1 | 2011 | 70 | 0.100 |
Why?
|
Prosthesis Fitting | 1 | 2011 | 22 | 0.100 |
Why?
|
Athletic Performance | 1 | 2011 | 18 | 0.100 |
Why?
|
Apoptosis | 2 | 2010 | 251 | 0.100 |
Why?
|
Logistic Models | 1 | 2012 | 407 | 0.100 |
Why?
|
Coated Materials, Biocompatible | 1 | 2011 | 41 | 0.100 |
Why?
|
Poloxamer | 1 | 2010 | 3 | 0.100 |
Why?
|
Surface-Active Agents | 1 | 2010 | 6 | 0.100 |
Why?
|
Fractures, Cartilage | 1 | 2010 | 4 | 0.100 |
Why?
|
Musculoskeletal System | 1 | 2010 | 6 | 0.100 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 33 | 0.090 |
Why?
|
Anisotropy | 1 | 2010 | 58 | 0.090 |
Why?
|
Suture Anchors | 1 | 2011 | 71 | 0.090 |
Why?
|
Zygapophyseal Joint | 1 | 2010 | 44 | 0.090 |
Why?
|
Neurophysins | 1 | 2009 | 1 | 0.090 |
Why?
|
Dermoscopy | 1 | 2009 | 1 | 0.090 |
Why?
|
Vasopressins | 1 | 2009 | 6 | 0.090 |
Why?
|
Elasticity | 2 | 2004 | 39 | 0.090 |
Why?
|
Immunoblotting | 1 | 2009 | 55 | 0.090 |
Why?
|
Glycosaminoglycans | 1 | 2009 | 51 | 0.090 |
Why?
|
Culture Media, Conditioned | 2 | 2006 | 37 | 0.090 |
Why?
|
Confidence Intervals | 1 | 2009 | 96 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 130 | 0.090 |
Why?
|
Collagen | 1 | 2009 | 102 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2006 | 161 | 0.090 |
Why?
|
Athletic Injuries | 1 | 2011 | 178 | 0.090 |
Why?
|
Chicago | 1 | 2012 | 865 | 0.090 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 195 | 0.090 |
Why?
|
Chromium Compounds | 1 | 2009 | 4 | 0.090 |
Why?
|
Nitric Oxide | 1 | 2009 | 101 | 0.090 |
Why?
|
Exercise Therapy | 1 | 2010 | 112 | 0.090 |
Why?
|
Hypersensitivity, Delayed | 1 | 2009 | 21 | 0.090 |
Why?
|
Phosphates | 1 | 2009 | 20 | 0.090 |
Why?
|
Tissue Scaffolds | 1 | 2009 | 22 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2009 | 113 | 0.090 |
Why?
|
Tendon Injuries | 1 | 2011 | 196 | 0.080 |
Why?
|
Light | 1 | 2009 | 76 | 0.080 |
Why?
|
Retrospective Studies | 2 | 2020 | 3273 | 0.080 |
Why?
|
Surveys and Questionnaires | 1 | 2013 | 1184 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2008 | 55 | 0.080 |
Why?
|
Diskectomy | 1 | 2010 | 195 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2011 | 317 | 0.080 |
Why?
|
Chromium Alloys | 2 | 2017 | 48 | 0.080 |
Why?
|
Disease Progression | 3 | 2018 | 787 | 0.080 |
Why?
|
Bone Transplantation | 1 | 2009 | 224 | 0.080 |
Why?
|
Pain Measurement | 3 | 2018 | 462 | 0.080 |
Why?
|
Cyanates | 1 | 2006 | 1 | 0.070 |
Why?
|
Isocyanates | 1 | 2006 | 1 | 0.070 |
Why?
|
Isosorbide | 1 | 2006 | 2 | 0.070 |
Why?
|
Matrilin Proteins | 1 | 2006 | 3 | 0.070 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2006 | 4 | 0.070 |
Why?
|
Polyesters | 1 | 2006 | 5 | 0.070 |
Why?
|
Biophysical Phenomena | 1 | 2006 | 29 | 0.070 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 31 | 0.070 |
Why?
|
Capillaries | 2 | 2005 | 11 | 0.070 |
Why?
|
Arthrography | 1 | 2006 | 26 | 0.070 |
Why?
|
Orientation | 1 | 2006 | 10 | 0.070 |
Why?
|
Collagen Type II | 1 | 2006 | 31 | 0.070 |
Why?
|
Biophysics | 1 | 2006 | 38 | 0.070 |
Why?
|
Polymers | 1 | 2006 | 42 | 0.070 |
Why?
|
Porosity | 1 | 2006 | 71 | 0.070 |
Why?
|
Single-Blind Method | 1 | 2006 | 118 | 0.070 |
Why?
|
Permeability | 2 | 2005 | 134 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2006 | 127 | 0.070 |
Why?
|
Aggrecans | 1 | 2006 | 146 | 0.070 |
Why?
|
Robotics | 1 | 2005 | 10 | 0.070 |
Why?
|
Debridement | 1 | 2006 | 100 | 0.070 |
Why?
|
Treatment Failure | 1 | 2006 | 159 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2005 | 67 | 0.070 |
Why?
|
Physical Stimulation | 1 | 2004 | 12 | 0.060 |
Why?
|
Posture | 3 | 2015 | 78 | 0.060 |
Why?
|
Lumbar Vertebrae | 1 | 2010 | 487 | 0.060 |
Why?
|
Proteins | 1 | 2005 | 72 | 0.060 |
Why?
|
Arthroplasty | 1 | 2005 | 136 | 0.060 |
Why?
|
Prospective Studies | 1 | 2009 | 1811 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2004 | 74 | 0.060 |
Why?
|
Electrochemical Techniques | 2 | 2013 | 7 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2004 | 146 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2004 | 201 | 0.060 |
Why?
|
Disability Evaluation | 2 | 2019 | 327 | 0.060 |
Why?
|
Rest | 1 | 2003 | 32 | 0.060 |
Why?
|
Calibration | 2 | 2000 | 22 | 0.060 |
Why?
|
Leukocytes | 3 | 2007 | 43 | 0.050 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2021 | 11 | 0.050 |
Why?
|
Dielectric Spectroscopy | 2 | 2011 | 3 | 0.050 |
Why?
|
Rats, Zucker | 1 | 2021 | 9 | 0.050 |
Why?
|
Cohort Studies | 2 | 2019 | 1939 | 0.050 |
Why?
|
Ovariectomy | 1 | 2021 | 26 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 85 | 0.050 |
Why?
|
X-Ray Microtomography | 1 | 2021 | 72 | 0.050 |
Why?
|
Blood | 1 | 2001 | 25 | 0.050 |
Why?
|
gamma-Globulins | 1 | 2020 | 1 | 0.050 |
Why?
|
Temperature | 2 | 2012 | 76 | 0.050 |
Why?
|
Neutrophils | 1 | 2021 | 117 | 0.050 |
Why?
|
Albumins | 1 | 2020 | 33 | 0.050 |
Why?
|
Microscopy, Atomic Force | 1 | 2020 | 8 | 0.050 |
Why?
|
Shoulder Injuries | 2 | 2014 | 139 | 0.050 |
Why?
|
Spectrophotometry, Atomic | 1 | 2000 | 4 | 0.050 |
Why?
|
Ultrasonics | 1 | 2000 | 15 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 451 | 0.050 |
Why?
|
Forecasting | 1 | 2020 | 117 | 0.050 |
Why?
|
Absorptiometry, Photon | 2 | 2011 | 76 | 0.040 |
Why?
|
Rats | 1 | 2021 | 854 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2021 | 604 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 959 | 0.040 |
Why?
|
Cell Death | 2 | 2009 | 61 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 1998 | 27 | 0.040 |
Why?
|
Software | 1 | 1998 | 72 | 0.040 |
Why?
|
Muscle Fatigue | 1 | 2017 | 10 | 0.040 |
Why?
|
Torso | 1 | 2017 | 7 | 0.040 |
Why?
|
Hardness | 2 | 2012 | 6 | 0.040 |
Why?
|
Interleukins | 1 | 2017 | 37 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1998 | 219 | 0.040 |
Why?
|
Elbow | 1 | 2017 | 42 | 0.040 |
Why?
|
Biosensing Techniques | 1 | 2016 | 13 | 0.040 |
Why?
|
Electrodes | 1 | 2016 | 16 | 0.040 |
Why?
|
Patellar Ligament | 1 | 1997 | 52 | 0.040 |
Why?
|
Patella | 1 | 1997 | 81 | 0.040 |
Why?
|
Independent Living | 1 | 2019 | 281 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2007 | 63 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2020 | 1442 | 0.030 |
Why?
|
Photography | 1 | 2015 | 17 | 0.030 |
Why?
|
Medical Illustration | 1 | 2015 | 20 | 0.030 |
Why?
|
DNA | 1 | 2015 | 125 | 0.030 |
Why?
|
Body Height | 1 | 2015 | 33 | 0.030 |
Why?
|
Video Recording | 1 | 2015 | 47 | 0.030 |
Why?
|
Thorax | 1 | 2014 | 12 | 0.030 |
Why?
|
Exercise | 1 | 2019 | 468 | 0.030 |
Why?
|
Hot Temperature | 1 | 2013 | 23 | 0.030 |
Why?
|
Adhesiveness | 1 | 2013 | 1 | 0.030 |
Why?
|
Diffusion | 1 | 2013 | 28 | 0.030 |
Why?
|
Water | 1 | 2013 | 34 | 0.030 |
Why?
|
Knee Injuries | 1 | 2016 | 223 | 0.030 |
Why?
|
Nanoparticles | 1 | 2013 | 10 | 0.030 |
Why?
|
Europe | 1 | 2013 | 81 | 0.030 |
Why?
|
Hip Injuries | 1 | 2013 | 11 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 18 | 0.030 |
Why?
|
Microscopy | 1 | 2012 | 12 | 0.030 |
Why?
|
Electrons | 1 | 2012 | 19 | 0.030 |
Why?
|
Spectroscopy, Electron Energy-Loss | 1 | 2011 | 3 | 0.030 |
Why?
|
Spectrum Analysis, Raman | 1 | 2011 | 4 | 0.030 |
Why?
|
Serum | 1 | 2011 | 9 | 0.030 |
Why?
|
Postoperative Care | 1 | 2013 | 127 | 0.030 |
Why?
|
Dental Polishing | 1 | 2011 | 1 | 0.030 |
Why?
|
Sodium Hydroxide | 1 | 2011 | 1 | 0.030 |
Why?
|
Lactic Acid | 1 | 2011 | 16 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2012 | 24 | 0.030 |
Why?
|
Electric Capacitance | 1 | 2011 | 5 | 0.030 |
Why?
|
Electric Impedance | 1 | 2011 | 24 | 0.020 |
Why?
|
Reducing Agents | 1 | 2010 | 3 | 0.020 |
Why?
|
Free Radicals | 1 | 2010 | 9 | 0.020 |
Why?
|
Rupture | 1 | 2011 | 115 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 138 | 0.020 |
Why?
|
Talus | 1 | 2010 | 10 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 12 | 0.020 |
Why?
|
Models, Animal | 1 | 2011 | 126 | 0.020 |
Why?
|
Pyridines | 1 | 2010 | 42 | 0.020 |
Why?
|
Regression Analysis | 1 | 2011 | 298 | 0.020 |
Why?
|
Linear Models | 1 | 2011 | 254 | 0.020 |
Why?
|
Suture Techniques | 1 | 2011 | 141 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2010 | 108 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 145 | 0.020 |
Why?
|
Imidazoles | 1 | 2010 | 72 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 222 | 0.020 |
Why?
|
Wound Healing | 1 | 2010 | 168 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 288 | 0.020 |
Why?
|
Torque | 1 | 2009 | 27 | 0.020 |
Why?
|
Cumulative Trauma Disorders | 1 | 2009 | 16 | 0.020 |
Why?
|
Pain Management | 1 | 2010 | 143 | 0.020 |
Why?
|
Signal Transduction | 1 | 2010 | 482 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2007 | 43 | 0.020 |
Why?
|
Capillary Permeability | 1 | 2007 | 26 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 116 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2006 | 52 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2006 | 17 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2005 | 5 | 0.020 |
Why?
|
Body Weight | 1 | 2006 | 133 | 0.020 |
Why?
|
Microfluidics | 1 | 2005 | 8 | 0.020 |
Why?
|
Body Fluids | 1 | 2005 | 19 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2006 | 56 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2006 | 61 | 0.020 |
Why?
|
Hemodynamics | 1 | 2005 | 83 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 85 | 0.020 |
Why?
|
Mechanics | 1 | 2005 | 4 | 0.020 |
Why?
|
Nanostructures | 1 | 2005 | 12 | 0.020 |
Why?
|
Oxygen | 1 | 2005 | 85 | 0.020 |
Why?
|
Infant | 1 | 2005 | 531 | 0.010 |
Why?
|
Child, Preschool | 1 | 2005 | 642 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2003 | 92 | 0.010 |
Why?
|